rTMS for depression: The difficult transition from research to clinical practice

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Practice Guidelines

Background:

• The 2020 Royal Australian and New Zealand College of Psychiatrists guidelines for mood disorders sparked debate on repetitive transcranial magnetic stimulation (rTMS).
• A controversy emerged regarding the role of rTMS in the sequential care for routine depression treatment, highlighted in the Australian and New Zealand Journal of Psychiatry.

Purpose of the Study:

• To discuss the challenges in transitioning repetitive transcranial magnetic stimulation (rTMS) from research to clinical practice for depression management.
• To address the core issues of evidence interpretation and patient characterization for rTMS in treating depression.

Main Methods:

• Viewpoint discussion analyzing arguments presented in professional correspondences.
• Focus on the interpretation of evidence levels for rTMS efficacy in depression.
• Examination of patient profiles suitable for benefiting from rTMS treatment.

Main Results:

• The debate centers on two key issues: the interpretation of evidence for rTMS in depression and defining which patients benefit most.
• There is a recognized difficulty in translating research findings on rTMS into routine clinical application for depression.

Conclusions:

• Integrating neuromodulation techniques like rTMS into standard depression care requires careful consideration of evidence and patient selection.
• Further dialogue is needed to bridge the gap between research and clinical implementation of rTMS for mood disorders.